Selective	O
inhibition	O
of	O
nuclear	O
factor	O
-	O
kappaB	O
by	O
nuclear	O
factor	O
-	O
kappaB	O
essential	O
modulator	O
-	O
binding	O
domain	O
peptide	O
suppresses	O
the	O
metastasis	O
of	O
highly	O
metastatic	B-Cancer
oral	I-Cancer
squamous	I-Cancer
cell	I-Cancer
carcinoma	I-Cancer
.	O

Nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
activation	O
contributes	O
to	O
the	O
development	O
of	O
metastasis	O
,	O
thus	O
leading	O
to	O
a	O
poor	O
prognosis	O
in	O
many	O
cancers	B-Cancer
,	O
including	O
OSCC	B-Cancer
.	O

However	O
,	O
little	O
in	O
vivo	O
experimental	O
data	O
are	O
available	O
about	O
the	O
effects	O
of	O
NF	O
-	O
kappaB	O
inhibition	O
on	O
OSCC	B-Cancer
metastasis	O
.	O

OSCC	B-Cell
sublines	I-Cell
were	O
established	O
from	O
a	O
GFP	O
-	O
expressing	O
parental	B-Cell
cell	I-Cell
line	I-Cell
,	O
GSAS	B-Cell
,	O
and	O
designated	O
GSAS	B-Cell
/	I-Cell
N3	I-Cell
and	O
N5	B-Cell
according	O
to	O
the	O
in	O
vivo	O
passage	O
number	O
after	O
cervical	B-Multi-tissue_structure
lymph	I-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
by	O
a	O
serial	O
orthotopic	O
transplantation	O
model	O
.	O

In	O
vitro	O
migration	O
and	O
invasion	O
were	O
assessed	O
in	O
these	O
cells	B-Cell
,	O
and	O
the	O
NF	O
-	O
kappaB	O
activities	O
and	O
expression	O
of	O
NF	O
-	O
kappaB	O
-	O
regulated	O
metastasis	O
-	O
related	O
molecules	O
were	O
also	O
examined	O
.	O

In	O
in	O
vivo	O
experiments	O
,	O
the	O
metastasis	O
and	O
survival	O
of	O
tumor	B-Cancer
-	O
engrafted	O
mice	O
were	O
monitored	O
.	O

Furthermore	O
,	O
the	O
effects	O
of	O
a	O
selective	O
NF	O
-	O
kappaB	O
inhibitor	O
,	O
NEMO	O
-	O
binding	O
domain	O
(	O
NBD	O
)	O
peptide	O
,	O
on	O
metastasis	O
in	O
GSAS	B-Cell
/	I-Cell
N5	I-Cell
-	O
engrafted	O
mice	O
were	O
assessed	O
,	O
and	O
engrafted	O
tongue	B-Cancer
tumors	I-Cancer
were	O
immunohistochemically	O
examined	O
.	O

Highly	O
metastatic	B-Cell
GSAS	I-Cell
/	I-Cell
N3	I-Cell
and	O
N5	B-Cell
cells	I-Cell
showed	O
an	O
enhanced	O
NF	O
-	O
kappaB	O
activity	O
,	O
thus	O
contributing	O
to	O
increased	O
migration	O
,	O
invasion	O
,	O
and	O
a	O
poor	O
prognosis	O
compared	O
with	O
the	O
parent	O
cells	B-Cell
.	O

Furthermore	O
,	O
the	O
expression	O
levels	O
of	O
NF	O
-	O
kappaB	O
-	O
regulated	O
metastasis	O
-	O
related	O
molecules	O
,	O
such	O
as	O
fibronectin	O
,	O
beta1	O
integrin	O
,	O
MMP	O
-	O
1	O
,	O
-	O
2	O
,	O
-	O
9	O
,	O
and	O
-	O
14	O
,	O
and	O
VEGF	O
-	O
C	O
,	O
were	O
upregulated	O
in	O
the	O
highly	O
metastatic	B-Cell
cells	I-Cell
.	O

The	O
NBD	O
peptide	O
suppressed	O
metastasis	O
and	O
tongue	B-Cancer
tumor	I-Cancer
growth	O
in	O
GSAS	B-Cell
/	I-Cell
N5	I-Cell
-	O
inoculated	O
mice	O
,	O
and	O
was	O
accompanied	O
by	O
the	O
downregulation	O
of	O
the	O
NF	O
-	O
kappaB	O
-	O
regulated	O
metastasis	O
-	O
related	O
molecules	O
in	O
engrafted	O
tongue	B-Cancer
tumors	I-Cancer
.	O

Our	O
results	O
suggest	O
that	O
the	O
selective	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
activation	O
by	O
NBD	O
peptide	O
may	O
provide	O
an	O
effective	O
approach	O
for	O
the	O
treatment	O
of	O
highly	O
metastatic	B-Cancer
OSCC	I-Cancer
.	O

